Filing Details
- Accession Number:
- 0000899243-18-004667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-20 19:34:25
- Reporting Period:
- 2018-02-15
- Accepted Time:
- 2018-02-20 19:34:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1679039 | A. Michael Panzara | C/O Wave Life Sciences Ltd., 733 Concord Ave. Cambridge MA 02138 | Franchise Lead, Neurology | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-02-15 | 18,750 | $21.69 | 58,486 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-02-15 | 18,750 | $50.00 | 39,736 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (right to buy) | Disposition | 2018-02-15 | 18,750 | $0.00 | 18,750 | $21.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 131,250 | 2026-07-11 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
- The share option represented a right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on July 11, 2017, and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
